| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.053 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |